Clinical Trials Browser

Phase NA × OTHER × lenvatinib × Clear all

NCT07417800 2026-02-18

Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06740370 2025-08-14

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07077798 2025-07-22

Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT06622031 2025-01-13

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06061276 2024-09-23

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT04618367 2024-03-06

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Phase NA Completed

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

NCT06277024 2024-02-26

A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients

Phase NA Recruiting

Gastrointestinal

Stomach Neoplasms

NCT04642547 2023-08-01

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT04967495 2023-05-18

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05592197 2023-02-16

Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

Phase NA Withdrawn

Gastrointestinal

Advanced Hepatocellular Carcinoma

NCT03838796 2022-08-02

Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05339581 2022-04-27

iPLENTY-pvtt

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04443049 2021-10-05

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT04531228 2021-09-22

Thalen

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04961138 2021-07-14

Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04443322 2020-09-22

Dulect2020-1

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04444193 2020-06-23

Dulect2020-2

Phase NA Unknown

Endometrial Neoplasms